Call to Congress 2019
Every spring, the ADA convenes Call to Congress—bringing together hundreds of Diabetes Advocates to Capitol Hill to educate their members of Congress about the impact of diabetes, share their personal stories, and advocate for key federal priorities like federal funding to support diabetes research and programs, and access to adequate and affordable healthcare. Call to Congress serves as the premier advocacy campaign and convening for the ADA in empowering those affected by diabetes to tell their stories and drive positive change and support among congressional champions and key influencers.
Attendees include children and adults living with diabetes, parents and caretakers, health care professionals, and diabetes researchers—all of whom put a face on diabetes by sharing their stories on Capitol Hill. This advocacy platform gives Diabetes Advocates the training, direction and opportunity to have a voice in the decisions being made in Washington that directly impact their lives and the lives of those they love.
While Call to Congress culminates with an in-person event in Washington each spring, the initiative encompasses a far larger and longer engagement campaign throughout the year, giving more than 500,000 Diabetes Advocates a voice in what matters most both at home and in Washington. Because of this advocacy, members of Congress and their staff not only learn about the impact of diabetes, they are moved to support and champion critical public policies benefiting individuals with and at risk for diabetes. Policy change and investments at the federal level move the nation closer to the ADA’s mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
The goal of Call to Congress, and our advocacy in general, is to educate Congress about the massive impact of diabetes and gain their commitment to act in support for key resources, legislation, and programming to bend the curve of the diabetes epidemic in the future, and help individuals and families impacted by diabetes thrive.